BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bax BE, Levene M, Bain MD, Fairbanks LD, Filosto M, Kalkan Uçar S, Klopstock T, Kornblum C, Mandel H, Rahman S, Roubertie A, Scarpelli M, Sedgwick PM, Baru M, Sellos-Moura M, Price J, Horn P, Nirmalananthan N. Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial. J Clin Med 2019;8:E1096. [PMID: 31344955 DOI: 10.3390/jcm8081096] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Kipper K, Hecht M, Antunes NJ, Fairbanks LD, Levene M, Kalkan Uçar S, Schaefer A, Blakely EL, Bax BE. Quantification of Plasma and Urine Thymidine and 2'-Deoxyuridine by LC-MS/MS for the Pharmacodynamic Evaluation of Erythrocyte Encapsulated Thymidine Phosphorylase in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy. J Clin Med 2020;9:E788. [PMID: 32183169 DOI: 10.3390/jcm9030788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rahman S. Advances in the treatment of mitochondrial epilepsies. Epilepsy Behav 2019;101:106546. [PMID: 31677997 DOI: 10.1016/j.yebeh.2019.106546] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Aa N, Lu Y, Yu M, Tang H, Lu Z, Sun R, Wang L, Li C, Yang Z, Aa J, Kong X, Wang G. Plasma Metabolites Alert Patients With Chest Pain to Occurrence of Myocardial Infarction. Front Cardiovasc Med 2021;8:652746. [PMID: 33969016 DOI: 10.3389/fcvm.2021.652746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ramón J, Vila-Julià F, Molina-Granada D, Molina-Berenguer M, Melià MJ, García-Arumí E, Torres-Torronteras J, Cámara Y, Martí R. Therapy Prospects for Mitochondrial DNA Maintenance Disorders. Int J Mol Sci 2021;22:6447. [PMID: 34208592 DOI: 10.3390/ijms22126447] [Reference Citation Analysis]
5 Li Y, Raza F, Liu Y, Wei Y, Rong R, Zheng M, Yuan W, Su J, Qiu M, Li Y, Raza F, Liu Y, Wei Y, Rong R, Zheng M, Yuan W, Su J, Qiu M. Clinical progress and advanced research of red blood cells based drug delivery system. Biomaterials 2021;279:121202. [PMID: 34749072 DOI: 10.1016/j.biomaterials.2021.121202] [Reference Citation Analysis]
6 Glassman PM, Hood ED, Ferguson LT, Zhao Z, Siegel DL, Mitragotri S, Brenner JS, Muzykantov VR. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers. Adv Drug Deliv Rev 2021;178:113992. [PMID: 34597748 DOI: 10.1016/j.addr.2021.113992] [Reference Citation Analysis]
7 Li C, Qi Y, Feng J, Zhang X. Cell‐Based Bio‐Hybrid Delivery System for Disease Treatments. Adv NanoBio Res 2021;1:2000052. [DOI: 10.1002/anbr.202000052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial Diseases: Hope for the Future. Cell 2020;181:168-88. [PMID: 32220313 DOI: 10.1016/j.cell.2020.02.051] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 28.5] [Reference Citation Analysis]
9 Habibzadeh P, Silawi M, Dastsooz H, Bahramjahan S, Ezzatzadegan Jahromi S, Ostovan VR, Yavarian M, Mofatteh M, Faghihi MA. Clinical and molecular characterization of a patient with mitochondrial Neurogastrointestinal Encephalomyopathy. BMC Gastroenterol 2020;20:142. [PMID: 32384880 DOI: 10.1186/s12876-020-01280-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Koleva L, Bovt E, Ataullakhanov F, Sinauridze E. Erythrocytes as Carriers: From Drug Delivery to Biosensors. Pharmaceutics 2020;12:E276. [PMID: 32197542 DOI: 10.3390/pharmaceutics12030276] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
11 Pappalardo P, Benoist JF, Bax BE, Carra-Dallière C, Marelli C, Levene M, Begue L, Rolland A, Flori N, Rivier F, Blanchet C, Munnich A, Altwegg R, Meyer P, Roubertie A. Pregnancy in MNGIE: a clinical and metabolic honeymoon. Ann Clin Transl Neurol 2020;7:2484-8. [PMID: 33159497 DOI: 10.1002/acn3.51202] [Reference Citation Analysis]
12 Mas R, Magy L, Jésus P, Ly K, Archambeaud F, Gondran G. [Muscular weakness and weight loss in à 44 year-old man]. Rev Med Interne 2021;42:887-90. [PMID: 34776277 DOI: 10.1016/j.revmed.2021.10.007] [Reference Citation Analysis]
13 Mencias M, Levene M, Blighe K, Bax BE, On Behalf Of The Project Group. Circulating miRNAs as Biomarkers for Mitochondrial Neuro-Gastrointestinal Encephalomyopathy. Int J Mol Sci 2021;22:3681. [PMID: 33916195 DOI: 10.3390/ijms22073681] [Reference Citation Analysis]
14 Protasov E, Koleva L, Bovt E, Ataullakhanov FI, Sinauridze E. Theoretical Analysis of the Built-in Metabolic Pathway Effect on the Metabolism of Erythrocyte-Bioreactors That Neutralize Ammonium. Metabolites 2021;11:36. [PMID: 33419113 DOI: 10.3390/metabo11010036] [Reference Citation Analysis]
15 Rossi L, Pierigè F, Bregalda A, Magnani M. Preclinical developments of enzyme-loaded red blood cells. Expert Opin Drug Deliv 2021;18:43-54. [PMID: 32924643 DOI: 10.1080/17425247.2020.1822320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Bax BE. Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment. J Transl Genet Genom 2020;4:1-16. [PMID: 32914088 DOI: 10.20517/jtgg.2020.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 Rossi L, Pierigè F, Aliano MP, Magnani M. Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies. BioDrugs 2020;34:265-72. [PMID: 32198632 DOI: 10.1007/s40259-020-00415-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
18 Lopez-Gomez C, Sanchez-Quintero MJ, Lee EJ, Kleiner G, Tadesse S, Xie J, Akman HO, Gao G, Hirano M. Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency. Ann Neurol 2021. [PMID: 34338329 DOI: 10.1002/ana.26185] [Reference Citation Analysis]
19 Pitceathly RDS, Keshavan N, Rahman J, Rahman S. Moving towards clinical trials for mitochondrial diseases. J Inherit Metab Dis 2021;44:22-41. [PMID: 32618366 DOI: 10.1002/jimd.12281] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
20 Bax BE. Erythrocytes as Carriers of Therapeutic Enzymes. Pharmaceutics 2020;12:E435. [PMID: 32397259 DOI: 10.3390/pharmaceutics12050435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Meinders M, Shoemark D, Dobbe JGG, Streekstra GJ, Frayne J, Toye AM. Expression and Retention of Thymidine Phosphorylase in Cultured Reticulocytes as a Novel Treatment for MNGIE. Mol Ther Methods Clin Dev 2020;17:822-30. [PMID: 32368563 DOI: 10.1016/j.omtm.2020.03.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]